Title
A pyrrolo-pyrimidine derivative targets human primary AML stem cells in vivo.
Document Type
Article
Publication Date
4-17-2013
Keywords
Adult, Aged, Animals, Antineoplastic Agents, Bone Marrow Transplantation, Crystallography, X-Ray, Drug Resistance, Neoplasm, Female, Hematopoiesis, Humans, Leukemia, Myeloid, Acute, Male, Mice, Middle Aged, Neoplastic Stem Cells, Protein Kinase Inhibitors, Proto-Oncogene Proteins c-hck, Pyrimidines, Pyrroles, RNA, Small Interfering, Small Molecule Libraries, Tumor Cells, Cultured, Young Adult
JAX Source
Sci Transl Med 2013 Apr 17; 5(176):176ra32
PMID
23596204
Abstract
Leukemia stem cells (LSCs) that survive conventional chemotherapy are thought to contribute to disease relapse, leading to poor long-term outcomes for patients with acute myeloid leukemia (AML). We previously identified a Src-family kinase (SFK) member, hematopoietic cell kinase (HCK), as a molecular target that is highly differentially expressed in human primary LSCs compared with human normal hematopoietic stem cells (HSCs). We performed a large-scale chemical library screen that integrated a high-throughput enzyme inhibition assay, in silico binding prediction, and crystal structure determination and found a candidate HCK inhibitor, RK-20449, a pyrrolo-pyrimidine derivative with an enzymatic IC50 (half maximal inhibitory concentration) in the subnanomolar range. A crystal structure revealed that RK-20449 bound the activation pocket of HCK. In vivo administration of RK-20449 to nonobese diabetic (NOD)/severe combined immunodeficient (SCID)/IL2rg(null) mice engrafted with highly aggressive therapy-resistant AML significantly reduced human LSC and non-stem AML burden. By eliminating chemotherapy-resistant LSCs, RK-20449 may help to prevent relapse and lead to improved patient outcomes in AML. Sci Transl Med 2013 Apr 17; 5(176):176ra32
Recommended Citation
Saito, Yoriko; Yuki, Hitomi; Kuratani, Mitsuo; Hashizume, Yoshinobu; Takagi, Shinsuke; Honma, Teruki; Tanaka, Akiko; Shirouzu, Mikako; Mikuni, Junko; Handa, Noriko; Ogahara, Ikuko; Sone, Akiko; Najima, Yuho; Tomabechi, Yuri; Wakiyama, Motoaki; Uchida, Naoyuki; Tomizawa-Murasawa, Mariko; Kaneko, Akiko; Tanaka, Satoshi; Suzuki, Nahoko; Kajita, Hiroshi; Aoki, Yuki; Ohara, Osamu; Shultz, Leonard D.; Fukami, Takehiro; Goto, Toshio; Taniguchi, Shuichi; Yokoyama, Shigeyuki; and Ishikawa, Fumihiko, "A pyrrolo-pyrimidine derivative targets human primary AML stem cells in vivo." (2013). Faculty Research 2013. 54.
https://mouseion.jax.org/stfb2013/54